A Study of Evorpacept Combined With Other AntiCancer Therapies in People With Breast Cancer

Full Title

A Phase 1b / 2, Multicenter, Multi Arm Study of Evorpacept in Combination with Anti-cancer Therapies in Advanced / Metastatic Malignancies (ASPEN-09)

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Shanu Modi’s office at 646-888-4564.

Protocol
26-188
Phase
Phase II (phase 2)
Investigator
Co-Investigators
Diseases
ClinicalTrials.gov ID
NCT07007559